(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 ...

Researchers at The Tisch Cancer Institute at Mount Sinai have uncovered a major reason why some colorectal cancers (CRC) ...

(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year ...

IN8bio (INAB) announced new clinical data from the ongoing Phase 1 investigator-sponsored trial of INB-100, an allogeneic gamma-delta T cell ...

NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...

Growing up, Dayna James never thought she’d willingly step foot on a plantation, let alone thank God for one. On an early ...

IN8bio Inc. (NASDAQ:INAB) shares received a positive update from Jones Trading as analyst Soumit Roy upgraded the company's stock rating from Hold to Buy. Along with the rating change, Roy established ...

A federal judge on Monday prevented the National Institutes of Health from changing the percentage that universities and ...

A ‘teal’ candidate contesting a seat in Sydney’s upper North Shore once worked as a consultant for big tobacco, and published ...

Jennison Associates LLC acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 4th quarter, ...

KU has nominated four juniors for a prestigious scholarship that recognizes their academic excellence and undergraduate ...